Effects of SQ109 on QTc Interval in Healthy Subjects

NCT01874314 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

NIH

Sponsor class

Conditions

Tuberculosis

Interventions

DRUG: SQ109
OTHER: SQ109 Placebo
DRUG: Moxifloxacin

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)